84 related articles for article (PubMed ID: 21568673)
1. Uroporphyrinogen decarboxylase: optimizing radiotherapy for head and neck cancer.
Ito E; Yip KW; Liu FF
Future Oncol; 2011 May; 7(5):595-7. PubMed ID: 21568673
[No Abstract] [Full Text] [Related]
2. Uroporphyrinogen decarboxylase is a radiosensitizing target for head and neck cancer.
Ito E; Yue S; Moriyama EH; Hui AB; Kim I; Shi W; Alajez NM; Bhogal N; Li G; Datti A; Schimmer AD; Wilson BC; Liu PP; Durocher D; Neel BG; O'Sullivan B; Cummings B; Bristow R; Wrana J; Liu FF
Sci Transl Med; 2011 Jan; 3(67):67ra7. PubMed ID: 21270338
[TBL] [Abstract][Full Text] [Related]
3. Beyond detection: novel applications for PET imaging to guide cancer therapy.
Rajendran JG; Mankoff DA
J Nucl Med; 2007 Jun; 48(6):855-6. PubMed ID: 17536105
[No Abstract] [Full Text] [Related]
4. Head and neck cancers: making headway in their treatment?
McCann J
J Natl Cancer Inst; 2000 Jan; 92(1):11-3. PubMed ID: 10620623
[No Abstract] [Full Text] [Related]
5. Targeting hypoxia in head and neck cancer.
Peters LJ
Acta Oncol; 2001; 40(8):937-40. PubMed ID: 11845958
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia in head and neck cancer: studies with hypoxic positron emission tomography imaging and hypoxic cytotoxins.
Rischin D; Fisher R; Peters L; Corry J; Hicks R
Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S61-3. PubMed ID: 17848298
[No Abstract] [Full Text] [Related]
7. Advances in radiation therapy of head and neck cancer.
Popovtzer A; Eisbruch A
Expert Rev Anticancer Ther; 2008 Apr; 8(4):633-44. PubMed ID: 18402530
[TBL] [Abstract][Full Text] [Related]
8. Organ porphyrins and uroporphyrinogen decarboxylase activity in a case of non-functioning adrenocortical carcinoma.
Zawirska B
Mater Med Pol; 1990; 22(2):79-81. PubMed ID: 2102982
[TBL] [Abstract][Full Text] [Related]
9. Radiobiologic research for head and neck cancer therapy. Therapeutic implications.
Weichselbaum RR; Rose CM; Ervin TJ; Miller D
Arch Otolaryngol; 1983 Dec; 109(12):792-6. PubMed ID: 6357165
[TBL] [Abstract][Full Text] [Related]
10. Management of 'in-field' skin toxicity in head and neck cancer patients treated with combined cetuximab and radiotherapy.
Cante D; La Porta MR; Franco P; Sciacero P; Girelli GF; Marra A; Numico G; Denaro N; Russi EG; Ricardi U
Oncology; 2013; 85(5):257-61. PubMed ID: 24192693
[TBL] [Abstract][Full Text] [Related]
11. [Cancer and radiotherapy. (6) Present status and problems of radiotherapy].
Tsunemoto H
Iyodenshi To Seitai Kogaku; 1983 Feb; 21(1):36-47. PubMed ID: 6314002
[No Abstract] [Full Text] [Related]
12. Cisplatin as a radiosensitizer in the treatment of locally advanced head and neck cancer.
Altundag O; Altundag K; Morandi P; Hanrahan E
Oral Oncol; 2005 Apr; 41(4):435. PubMed ID: 15792617
[No Abstract] [Full Text] [Related]
13. Combining radiotherapy with systemic therapies.
Vokes EE
Clin Adv Hematol Oncol; 2008 Mar; 6(3):167-9. PubMed ID: 18391914
[No Abstract] [Full Text] [Related]
14. [Chemoradiotherapy for patients with advanced head and neck cancer].
Tsukuda M
Gan To Kagaku Ryoho; 1997 Nov; 24(14):2049-57. PubMed ID: 9388513
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness of the radiosensitizer cisplatin. A pilot study].
Klima A; Szepesi S
Laryngol Rhinol Otol (Stuttg); 1987 Sep; 66(9):457-9. PubMed ID: 3683038
[TBL] [Abstract][Full Text] [Related]
16. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?
Vordermark D; Brown JM
Strahlenther Onkol; 2003 Dec; 179(12):801-11. PubMed ID: 14652668
[TBL] [Abstract][Full Text] [Related]
17. Uroporphyrinogen decarboxylase and porphyrins in the tissue of human clear-cell renal carcinoma and in its maternal renal cortex.
Zawirska B
Neoplasma; 1989; 36(2):207-13. PubMed ID: 2716925
[TBL] [Abstract][Full Text] [Related]
18. Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94).
Ghadjar P; Simcock M; Studer G; Allal AS; Ozsahin M; Bernier J; Töpfer M; Zimmermann F; Betz M; Glanzmann C; Aebersold DM;
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):524-31. PubMed ID: 21300466
[TBL] [Abstract][Full Text] [Related]
19. [Clinical results and experiences with combination of radiotherapy and radiosensitizing agents].
Ikeda H
Gan No Rinsho; 1990 Oct; 36(13):2244-7. PubMed ID: 1701197
[TBL] [Abstract][Full Text] [Related]
20. Preoperative radiotherapy and bevacizumab for angiosarcoma of the head and neck: two case studies.
Koontz BF; Miles EF; Rubio MA; Madden JF; Fisher SR; Scher RL; Brizel DM
Head Neck; 2008 Feb; 30(2):262-6. PubMed ID: 17685450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
